Advanced Material Catheter (AMCath), a minimally invasive endocardial catheter for the delivery of fast-gelling covalently cross-linked hyaluronic acid hydrogels
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
30354912
DOI
10.1177/0885328218805878
Knihovny.cz E-zdroje
- Klíčová slova
- Hydrogel, catheter, hyaluronic acid, minimally invasive delivery, myocardial infarction,
- MeSH
- biokompatibilní materiály aplikace a dávkování MeSH
- buněčné linie MeSH
- design vybavení MeSH
- hydrogely aplikace a dávkování MeSH
- imobilizované buňky cytologie transplantace MeSH
- infarkt myokardu terapie MeSH
- injekce MeSH
- kmenové buňky cytologie MeSH
- kyselina hyaluronová aplikace a dávkování MeSH
- lékové transportní systémy přístrojové vybavení MeSH
- lidé MeSH
- prasata MeSH
- reagencia zkříženě vázaná aplikace a dávkování MeSH
- srdeční katétry * MeSH
- transplantace kmenových buněk MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- biokompatibilní materiály MeSH
- hydrogely MeSH
- kyselina hyaluronová MeSH
- reagencia zkříženě vázaná MeSH
Injectable hydrogels that aim to mechanically stabilise the weakened left ventricle wall to restore cardiac function or to deliver stem cells in cardiac regenerative therapy have shown promising data. However, the clinical translation of hydrogel-based therapies has been limited due to difficulties injecting them through catheters. We have engineered a novel catheter, Advanced Materials Catheter (AMCath), that overcomes translational hurdles associated with delivering fast-gelling covalently cross-linked hyaluronic acid hydrogels to the myocardium. We developed an experimental technique to measure the force required to inject such hydrogels and determined the mechanical/viscoelastic properties of the resulting hydrogels. The preliminary in vivo feasibility of delivering fast-gelling hydrogels through AMCath was demonstrated by accessing the porcine left ventricle and showing that the hydrogel was retained in the myocardium post-injection (three 200 μL injections delivered, 192, 204 and 183 μL measured). However, the mechanical properties of the hydrogels were reduced by passage through AMCath (≤20.62% reduction). We have also shown AMCath can be used to deliver cardiopoietic adipose-derived stem cell-loaded hydrogels without compromising the viability (80% viability) of the cells in vitro. Therefore, we show that hydrogel/catheter compatibility issues can be overcome as we have demonstrated the minimally invasive delivery of a fast-gelling covalently cross-linked hydrogel to the beating myocardium.
Boston Scientific Ballybrit Business Park Ballybrit Galway Ireland
Cellular and Molecular Imaging Core Royal College of Surgeons in Ireland Dublin Ireland
Celyad SA Mont Saint Guibert Belgium
Explora Biotech Srl G Peroni Rome Italy
R and D department Contipro Dolni Dobrouc Czech Republic
School of Pharmacy Royal College of Surgeons in Ireland Dublin Ireland
Citace poskytuje Crossref.org